Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
16
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| FMR LLC | 10% Owner | 25 | $0 | $21.5K | 2025-11-13 |
| Population Health Partners GP, LLC | 10% Owner | 2 | $0 | $0 | 2025-11-13 |
| Hubbard Brian | Chief Scientific Officer | 6 | $0 | $0 | 2025-11-13 |
| Bernard Christopher Whitten | See Remarks | 6 | $0 | $0 | 2025-11-13 |
| Marso Steven | Chief Medical Officer | 6 | $0 | $0 | 2025-11-13 |
| Pinto Joshua | Director | 7 | $0 | $0 | 2025-11-13 |
| ARCH Venture Partners XII, LLC | Director, 10% Owner | 2 | $0 | $0 | 2025-11-13 |
| Visioli Christopher | Chief Financial Officer | 6 | $0 | $0 | 2025-11-13 |
| Lang Matthew | Chief Legal Officer | 5 | $0 | $0 | 2025-11-13 |
| Burow Kristina | Director, 10% Owner | 18 | $40.00M | $0 | 2025-11-13 |
| Stonehouse Jon P | Director | 4 | $0 | $0 | 2025-11-13 |
| MEANWELL CLIVE | Executive Chairman | 6 | $0 | $0 | 2025-11-13 |
| BERNS PAUL L | Director | 12 | $14.22M | $0 | 2025-11-13 |
| Validae Health, L.P. | 10% Owner | 1 | $0 | $0 | 2025-11-11 |
| GILLIS STEVEN | 10% Owner | 9 | $40.00M | $0 | 2025-02-03 |
| Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | 10% Owner | 2 | $0 | $0 | 2025-01-30 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Bernard Christopher Whitten | See Remarks | D To issuer deriv | 2025-11-13 | 2025-11-13 | 1,702,328 | — | $0 | 0 | SEC↗ |
| Bernard Christopher Whitten | See Remarks | D To issuer deriv | 2025-11-13 | 2025-11-13 | 348,750 | — | $0 | 0 | SEC↗ |
| Bernard Christopher Whitten | See Remarks | A Award deriv | 2025-11-13 | 2025-11-13 | 21,250 | — | $0 | 21,250 | SEC↗ |
| MEANWELL CLIVE | EXECUTIVE CHAIRMAN | D To issuer deriv | 2025-11-13 | 2025-11-13 | 297,907 | — | $0 | 0 | SEC↗ |
| MEANWELL CLIVE | EXECUTIVE CHAIRMAN | A Award deriv | 2025-11-13 | 2025-11-13 | 5,375 | — | $0 | 5,375 | SEC↗ |
| MEANWELL CLIVE | EXECUTIVE CHAIRMAN | D To issuer deriv | 2025-11-13 | 2025-11-13 | 32,250 | — | $0 | 0 | SEC↗ |
| Visioli Christopher | CHIEF FINANCIAL OFFICER | D To issuer deriv | 2025-11-13 | 2025-11-13 | 255,349 | — | $0 | 0 | SEC↗ |
| Visioli Christopher | CHIEF FINANCIAL OFFICER | D To issuer deriv | 2025-11-13 | 2025-11-13 | 340,465 | — | $0 | 0 | SEC↗ |
| Visioli Christopher | CHIEF FINANCIAL OFFICER | D To issuer deriv | 2025-11-13 | 2025-11-13 | 150,000 | — | $0 | 0 | SEC↗ |
| Visioli Christopher | CHIEF FINANCIAL OFFICER | A Award deriv | 2025-11-13 | 2025-11-13 | 21,250 | — | $0 | 21,250 | SEC↗ |
| Stonehouse Jon P | Director | D To issuer deriv | 2025-11-13 | 2025-11-13 | 47,730 | — | $0 | 0 | SEC↗ |
| Stonehouse Jon P | Director | A Award deriv | 2025-11-13 | 2025-11-13 | 2,688 | — | $0 | 2,688 | SEC↗ |
| Hubbard Brian | CHIEF SCIENTIFIC OFFICER | D To issuer deriv | 2025-11-13 | 2025-11-13 | 319,186 | — | $0 | 0 | SEC↗ |
| Hubbard Brian | CHIEF SCIENTIFIC OFFICER | A Award deriv | 2025-11-13 | 2025-11-13 | 17,000 | — | $0 | 17,000 | SEC↗ |
| Hubbard Brian | CHIEF SCIENTIFIC OFFICER | D To issuer deriv | 2025-11-13 | 2025-11-13 | 120,000 | — | $0 | 0 | SEC↗ |
| Hubbard Brian | CHIEF SCIENTIFIC OFFICER | D To issuer deriv | 2025-11-13 | 2025-11-13 | 106,395 | — | $0 | 0 | SEC↗ |
| Pinto Joshua | Director | D To issuer deriv | 2025-11-13 | 2025-11-13 | 148,953 | — | $0 | 0 | SEC↗ |
| Pinto Joshua | Director | A Award deriv | 2025-11-13 | 2025-11-13 | 2,688 | — | $0 | 2,688 | SEC↗ |
| Pinto Joshua | Director | D To issuer deriv | 2025-11-13 | 2025-11-13 | 16,125 | — | $0 | 0 | SEC↗ |
| Burow Kristina | Director | D To issuer deriv | 2025-11-13 | 2025-11-13 | 148,953 | — | $0 | 0 | SEC↗ |
| Burow Kristina | Director | A Award deriv | 2025-11-13 | 2025-11-13 | 2,688 | — | $0 | 2,688 | SEC↗ |
| Burow Kristina | Director | D To issuer deriv | 2025-11-13 | 2025-11-13 | 16,125 | — | $0 | 0 | SEC↗ |
| Lang Matthew | CHIEF LEGAL OFFICER | D To issuer deriv | 2025-11-13 | 2025-11-13 | 46,875 | — | $0 | 0 | SEC↗ |
| Lang Matthew | CHIEF LEGAL OFFICER | A Award deriv | 2025-11-13 | 2025-11-13 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Lang Matthew | CHIEF LEGAL OFFICER | D To issuer deriv | 2025-11-13 | 2025-11-13 | 325,000 | — | $0 | 0 | SEC↗ |
| BERNS PAUL L | Director | A Award deriv | 2025-11-13 | 2025-11-13 | 4,031 | — | $0 | 4,031 | SEC↗ |
| BERNS PAUL L | Director | D To issuer deriv | 2025-11-13 | 2025-11-13 | 24,188 | — | $0 | 0 | SEC↗ |
| BERNS PAUL L | Director | D To issuer deriv | 2025-11-13 | 2025-11-13 | 223,430 | — | $0 | 0 | SEC↗ |
| Marso Steven | CHIEF MEDICAL OFFICER | A Award deriv | 2025-11-13 | 2025-11-13 | 17,000 | — | $0 | 17,000 | SEC↗ |
| Marso Steven | CHIEF MEDICAL OFFICER | D To issuer deriv | 2025-11-13 | 2025-11-13 | 829,885 | — | $0 | 0 | SEC↗ |
| Marso Steven | CHIEF MEDICAL OFFICER | D To issuer deriv | 2025-11-13 | 2025-11-13 | 21,279 | — | $0 | 0 | SEC↗ |
| Marso Steven | CHIEF MEDICAL OFFICER | D To issuer deriv | 2025-11-13 | 2025-11-13 | 120,000 | — | $0 | 0 | SEC↗ |
| Bernard Christopher Whitten | See Remarks | D To issuer | 2025-11-13 | 2025-11-13 | 21,250 | — | $0 | 0 | SEC↗ |
| Bernard Christopher Whitten | See Remarks | D To issuer | 2025-11-13 | 2025-11-13 | 12,767,462 | — | $0 | 0 | SEC↗ |
| MEANWELL CLIVE | EXECUTIVE CHAIRMAN | D To issuer | 2025-11-13 | 2025-11-13 | 5,375 | — | $0 | 0 | SEC↗ |
| MEANWELL CLIVE | EXECUTIVE CHAIRMAN | D To issuer | 2025-11-13 | 2025-11-13 | 12,767,462 | — | $0 | 0 | SEC↗ |
| Visioli Christopher | CHIEF FINANCIAL OFFICER | D To issuer | 2025-11-13 | 2025-11-13 | 21,250 | — | $0 | 0 | SEC↗ |
| Stonehouse Jon P | Director | D To issuer | 2025-11-13 | 2025-11-13 | 2,688 | — | $0 | 0 | SEC↗ |
| Hubbard Brian | CHIEF SCIENTIFIC OFFICER | D To issuer | 2025-11-13 | 2025-11-13 | 17,000 | — | $0 | 0 | SEC↗ |
| Pinto Joshua | Director | D To issuer | 2025-11-13 | 2025-11-13 | 2,688 | — | $0 | 0 | SEC↗ |
| Burow Kristina | Director | D To issuer | 2025-11-13 | 2025-11-13 | 2,688 | — | $0 | 0 | SEC↗ |
| Burow Kristina | Director | D To issuer | 2025-11-13 | 2025-11-13 | 17,070,904 | — | $0 | 0 | SEC↗ |
| Burow Kristina | Director | D To issuer | 2025-11-13 | 2025-11-13 | 8,313,680 | — | $0 | 0 | SEC↗ |
| Burow Kristina | Director | D To issuer | 2025-11-13 | 2025-11-13 | 7,523,682 | — | $0 | 0 | SEC↗ |
| Burow Kristina | Director | D To issuer | 2025-11-13 | 2025-11-13 | 18,503,128 | — | $0 | 0 | SEC↗ |
| Population Health Partners GP, | 10% Owner | D To issuer | 2025-11-13 | 2025-11-13 | 127,675 | — | $0 | 0 | SEC↗ |
| Population Health Partners GP, | 10% Owner | D To issuer | 2025-11-13 | 2025-11-13 | 12,639,787 | — | $0 | 0 | SEC↗ |
| Lang Matthew | CHIEF LEGAL OFFICER | D To issuer | 2025-11-13 | 2025-11-13 | 12,500 | — | $0 | 0 | SEC↗ |
| BERNS PAUL L | Director | D To issuer | 2025-11-13 | 2025-11-13 | 8,313,680 | — | $0 | 0 | SEC↗ |
| BERNS PAUL L | Director | D To issuer | 2025-11-13 | 2025-11-13 | 4,031 | — | $0 | 0 | SEC↗ |
| BERNS PAUL L | Director | D To issuer | 2025-11-13 | 2025-11-13 | 7,523,682 | — | $0 | 0 | SEC↗ |
| BERNS PAUL L | Director | D To issuer | 2025-11-13 | 2025-11-13 | 957,559 | — | $0 | 0 | SEC↗ |
| Marso Steven | CHIEF MEDICAL OFFICER | D To issuer | 2025-11-13 | 2025-11-13 | 17,000 | — | $0 | 0 | SEC↗ |
| ARCH Venture Partners XII, LLC | Director, 10% Owner | D To issuer | 2025-11-13 | 2025-11-14 | 18,503,128 | — | $0 | 0 | SEC↗ |
| ARCH Venture Partners XII, LLC | Director, 10% Owner | D To issuer | 2025-11-13 | 2025-11-14 | 8,313,680 | — | $0 | 0 | SEC↗ |
| FMR LLC | 10% Owner | J Other | 2025-11-13 | 2025-11-17 | 2,230,450 | — | $0 | 0 | SEC↗ |
| FMR LLC | 10% Owner | J Other | 2025-11-13 | 2025-11-17 | 3,010 | — | $0 | 0 | SEC↗ |
| Validae Health, L.P. | 10% Owner | J Other | 2025-11-11 | 2025-11-13 | 12,767,462 | — | $0 | 0 | SEC↗ |
| FMR LLC | 10% Owner | G Gift | 2025-11-10 | 2025-11-12 | 860,722 | — | $0 | 2,230,450 | SEC↗ |
| FMR LLC | 10% Owner | J Other | 2025-11-03 | 2025-11-05 | 2,356,274 | — | $0 | 2,356,274 | SEC↗ |
| FMR LLC | 10% Owner | J Other | 2025-11-03 | 2025-11-05 | 2,115 | — | $0 | 3,010 | SEC↗ |
| FMR LLC | 10% Owner | J Other | 2025-11-03 | 2025-11-05 | 47,843 | — | $0 | 0 | SEC↗ |
| FMR LLC | 10% Owner | J Other | 2025-11-03 | 2025-11-05 | 2,356,081 | — | $0 | 0 | SEC↗ |
| FMR LLC | 10% Owner | J Other | 2025-11-03 | 2025-11-05 | 3,189,540 | — | $0 | 0 | SEC↗ |
| FMR LLC | 10% Owner | J Other | 2025-11-03 | 2025-11-05 | 2,617,340 | — | $0 | 3,091,172 | SEC↗ |
| FMR LLC | 10% Owner | S Sale | 2025-11-03 | 2025-11-05 | 193 | $61.23 | $11.8K | 2,356,081 | SEC↗ |
| FMR LLC | 10% Owner | J Other | 2025-11-03 | 2025-11-05 | 47,843 | — | $0 | 47,843 | SEC↗ |
| FMR LLC | 10% Owner | G Gift | 2025-10-06 | 2025-10-08 | 633,715 | — | $0 | 473,832 | SEC↗ |
| FMR LLC | 10% Owner | S Sale | 2025-09-02 | 2025-09-04 | 268 | $36.00 | $9.6K | 0 | SEC↗ |
| FMR LLC | 10% Owner | J Other | 2025-09-02 | 2025-09-04 | 1,350,000 | — | $0 | 3,189,540 | SEC↗ |
| FMR LLC | 10% Owner | J Other | 2025-09-02 | 2025-09-04 | 997,044 | — | $0 | 268 | SEC↗ |
| FMR LLC | 10% Owner | J Other | 2025-09-02 | 2025-09-04 | 1,134,258 | — | $0 | 1,134,258 | SEC↗ |
| FMR LLC | 10% Owner | J Other | 2025-09-02 | 2025-09-04 | 20,250 | — | $0 | 20,250 | SEC↗ |
| FMR LLC | 10% Owner | J Other | 2025-09-02 | 2025-09-04 | 20,250 | — | $0 | 0 | SEC↗ |
| FMR LLC | 10% Owner | J Other | 2025-09-02 | 2025-09-04 | 895 | — | $0 | 895 | SEC↗ |
| FMR LLC | 10% Owner | J Other | 2025-09-02 | 2025-09-04 | 997,312 | — | $0 | 997,312 | SEC↗ |
| FMR LLC | 10% Owner | J Other | 2025-09-02 | 2025-09-12 | 1,107,547 | — | $0 | 1,107,547 | SEC↗ |
| Pinto Joshua | Director | G Gift deriv | 2025-05-22 | 2025-05-22 | 148,953 | — | $0 | 0 | SEC↗ |
| Pinto Joshua | Director | G Gift deriv | 2025-05-22 | 2025-05-22 | 148,953 | — | $0 | 148,953 | SEC↗ |
| Marso Steven | Chief Medical Officer | A Award deriv | 2025-05-20 | 2025-05-22 | 120,000 | — | $0 | 120,000 | SEC↗ |
| Hubbard Brian | Chief Scientific Officer | A Award deriv | 2025-05-20 | 2025-05-22 | 120,000 | — | $0 | 120,000 | SEC↗ |
| BERNS PAUL L | Director | A Award deriv | 2025-05-20 | 2025-05-22 | 24,188 | — | $0 | 24,188 | SEC↗ |
| Bernard Christopher Whitten | President and CEO | A Award deriv | 2025-05-20 | 2025-05-22 | 348,750 | — | $0 | 348,750 | SEC↗ |
| Lang Matthew | Chief Legal Officer | A Award deriv | 2025-05-20 | 2025-05-22 | 46,875 | — | $0 | 46,875 | SEC↗ |
| Visioli Christopher | Chief Financial Officer | A Award deriv | 2025-05-20 | 2025-05-22 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Burow Kristina | Director | A Award deriv | 2025-05-20 | 2025-05-22 | 16,125 | — | $0 | 16,125 | SEC↗ |
| MEANWELL CLIVE | Executive Chairman | A Award deriv | 2025-05-20 | 2025-05-22 | 32,250 | — | $0 | 32,250 | SEC↗ |
| Pinto Joshua | Director | A Award deriv | 2025-05-20 | 2025-05-22 | 16,125 | — | $0 | 16,125 | SEC↗ |
| Stonehouse Jon P | Director | A Award deriv | 2025-04-28 | 2025-04-30 | 47,730 | $19.81 | $945.5K | 47,730 | SEC↗ |
| GILLIS STEVEN | 10% Owner | C Conversion deriv | 2025-02-03 | 2025-02-03 | 19,933,333 | — | $0 | 0 | SEC↗ |
| GILLIS STEVEN | 10% Owner | C Conversion deriv | 2025-02-03 | 2025-02-03 | 15,000,000 | — | $0 | 0 | SEC↗ |
| GILLIS STEVEN | 10% Owner | C Conversion deriv | 2025-02-03 | 2025-02-03 | 2,678,571 | — | $0 | 0 | SEC↗ |
| GILLIS STEVEN | 10% Owner | C Conversion deriv | 2025-02-03 | 2025-02-03 | 15,000,000 | — | $0 | 0 | SEC↗ |
| GILLIS STEVEN | 10% Owner | C Conversion deriv | 2025-02-03 | 2025-02-03 | 2,678,571 | — | $0 | 0 | SEC↗ |
| BERNS PAUL L | Director | C Conversion deriv | 2025-02-03 | 2025-02-03 | 2,678,571 | — | $0 | 0 | SEC↗ |
| BERNS PAUL L | Director | C Conversion deriv | 2025-02-03 | 2025-02-03 | 15,000,000 | — | $0 | 0 | SEC↗ |
| Burow Kristina | Director, 10% Owner | C Conversion deriv | 2025-02-03 | 2025-02-03 | 15,000,000 | — | $0 | 0 | SEC↗ |
| Burow Kristina | Director, 10% Owner | C Conversion deriv | 2025-02-03 | 2025-02-03 | 19,933,333 | — | $0 | 0 | SEC↗ |
| Burow Kristina | Director, 10% Owner | C Conversion deriv | 2025-02-03 | 2025-02-03 | 2,678,571 | — | $0 | 0 | SEC↗ |
| Burow Kristina | Director, 10% Owner | C Conversion deriv | 2025-02-03 | 2025-02-03 | 15,000,000 | — | $0 | 0 | SEC↗ |
| Burow Kristina | Director, 10% Owner | C Conversion deriv | 2025-02-03 | 2025-02-03 | 2,678,571 | — | $0 | 0 | SEC↗ |
| FMR LLC | 10% Owner | C Conversion deriv | 2025-02-03 | 2025-02-05 | 3,120,934 | — | $0 | 0 | SEC↗ |
| FMR LLC | 10% Owner | C Conversion deriv | 2025-02-03 | 2025-02-05 | 1,418,606 | — | $0 | 0 | SEC↗ |
| GILLIS STEVEN | 10% Owner | C Conversion | 2025-02-03 | 2025-02-03 | 7,523,682 | — | $0 | 7,523,682 | SEC↗ |
| GILLIS STEVEN | 10% Owner | P Buy | 2025-02-03 | 2025-02-03 | 1,432,224 | $18.00 | $25.78M | 18,503,128 | SEC↗ |
| GILLIS STEVEN | 10% Owner | P Buy | 2025-02-03 | 2025-02-03 | 789,998 | $18.00 | $14.22M | 8,313,680 | SEC↗ |
| GILLIS STEVEN | 10% Owner | C Conversion | 2025-02-03 | 2025-02-03 | 16,006,949 | — | $0 | 17,070,904 | SEC↗ |
| BERNS PAUL L | Director | C Conversion | 2025-02-03 | 2025-02-03 | 7,523,682 | — | $0 | 7,523,682 | SEC↗ |
| BERNS PAUL L | Director | P Buy | 2025-02-03 | 2025-02-03 | 789,998 | $18.00 | $14.22M | 8,313,680 | SEC↗ |
| Burow Kristina | Director, 10% Owner | P Buy | 2025-02-03 | 2025-02-03 | 789,998 | $18.00 | $14.22M | 8,313,680 | SEC↗ |
| Burow Kristina | Director, 10% Owner | C Conversion | 2025-02-03 | 2025-02-03 | 7,523,682 | — | $0 | 7,523,682 | SEC↗ |
| Burow Kristina | Director, 10% Owner | P Buy | 2025-02-03 | 2025-02-03 | 1,432,224 | $18.00 | $25.78M | 18,503,128 | SEC↗ |
| Burow Kristina | Director, 10% Owner | C Conversion | 2025-02-03 | 2025-02-03 | 16,006,949 | — | $0 | 17,070,904 | SEC↗ |
| FMR LLC | 10% Owner | C Conversion | 2025-02-03 | 2025-02-05 | 3,120,934 | — | $0 | 4,539,540 | SEC↗ |
| FMR LLC | 10% Owner | C Conversion | 2025-02-03 | 2025-02-05 | 1,418,606 | — | $0 | 1,418,606 | SEC↗ |
| Wellington Biomedical Innovati | 10% Owner | C Conversion deriv | 2025-01-30 | 2025-02-03 | 4,365,079 | — | $0 | 0 | SEC↗ |
| Wellington Biomedical Innovati | 10% Owner | C Conversion | 2025-01-30 | 2025-02-03 | 1,857,699 | — | $0 | 1,857,699 | SEC↗ |